Related Experiment Videos
Reversible myopathy due to labetalol
J K Willis1, A H Tilton, J C Harkin
1Department of Psychiatry, Tulane University, New Orleans, Louisiana.
Pediatric Neurology
|July 1, 1990
Summary
Labetalol treatment can cause severe muscle damage, known as myopathy, in children. Discontinuing the drug quickly reversed symptoms and restored muscle strength.
Area of Science:
- Pharmacology
- Neurology
- Pediatrics
Background:
- Labetalol is a medication commonly prescribed for hypertension.
- Understanding potential adverse effects in pediatric populations is crucial.
Observation:
- Two children developed severe generalized myopathy during labetalol therapy.
- Symptoms included proximal muscle weakness and significantly elevated creatine kinase levels.
Findings:
- Muscle biopsies confirmed rhabdomyolysis, a severe form of muscle breakdown.
- Discontinuation of labetalol led to immediate clinical improvement.
Implications:
- This suggests a potential causal link between labetalol and pediatric myopathy.
- Clinicians should consider monitoring for muscle-related side effects in children on labetalol.